Andrew's Buddies Corporation (also known as "FightSMA") was created to accelerate the search for a treatment and cure for spinal muscular atrophy (SMA), the number-one inherited cause of infant death. The organization pursues this objective by raising awareness and funding for SMA research.
The next submission deadline will be Friday, August 1, 2008.
Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer's Research The American Academy of Neurology (AAN) Foundation and the Alzheimer's Association are pleased to announce the Robert Katzman, MD, Clinical Research Training Fellowship in Alzheimer's disease research, a two-year fellowship. The fellowship is supported by the AAN Foundation and the Alzheimer's Association.
Mailing Address Mail application materials to: AAN Foundation Attn: Terry Heinz Grants Administrator 1080 Montreal Avenue St. Paul, MN 55116
The American Academy of Neurology (AAN) Foundation is pleased to announce five two-year fellowships to support clinical research training in the neurosciences. The fellowships are supported by the AAN, the AAN Foundation, and the AAN Foundation Corporate Roundtable.
Shih-Chun Wang Young Investigator Award
The Shih-Chun Wang Memorial Fund was established in 1998 in memory of Shih-Chun Wang, the Pfeiffer Professor of Pharmacology at Columbia University and a long-standing APS member. Wang was internationally recognized for his research contributions in the areas of neurophysiology and neuropharmacology with an emphasis on brain stem control mechanisms. The Shih-Chun Wang Young Investigator Award is given annually to an individual demonstrating outstanding promise based on his/her research program in the physiological sciences. Applications are accepted from members of APS working within the U.S. and holding an academic rank no higher than assistant professor. The award of $7,000 is designated for use in the awardee's research program. The award does not include any indirect cost reimbursement. The recipient receives complimentary registration to attend the meeting and a plaque presented at the APS Business Meeting held at the Experimental Biology meeting. Applications will now only be accepted via online submission. Please go to http://www.the-aps.org/awardapps to apply.
American Physiological Society (APS) For applications, contact the appropriate APS office as listed at 9650 Rockville Pike, Bethesda, MD 20814-3991. Phone: 301-634-7118; fax: 301-634-7242; e-mail: awards@the-aps.org
OVERVIEW OF THE CUREPSP RESEARCH PROGRAMThe Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports andpromotes research that can advance the understanding and treatment of progressivesupranuclear palsy (PSP) and corticobasal degeneration (CBD). CurePSP’s Research Programhas three components:INVESTIGATOR-INITIATED RESEARCHCurePSP promotes research that helps generate an integrated picture of PSP and CBD at themolecular, cellular, and clinical levels. CurePSP may offer grants of up to $100,000 per year forthree years, the award maximum and duration varying per submission cycle.CLINICAL TRIALSIn an effort to encourage investigators to plan and execute PSP/CBD clinical trials, CurePSPearmarks money for investigator-initiated clinical trials.CUREPSP- INITIATED RESEARCHCurePSP may encourage independent investigators to submit applications for its internallyinitiated research funding mechanism by issuing a request for applications (RFA).CurePSP is particularly interested in research that will help us:1. Understand the role of the tau gene and other genes in PSP and CBD.2. Understand the role of tau protein processing in PSP and CBD.3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD.4. Understand environmental factors that influence the development or course of PSP and CBD.5. Understand the series of changes brain cells pass through in PSP and CBD as they progressfrom healthy neurons to dysfunctional neurons.6. Characterize the natural history of PSP and CBD in order to develop outcome measures forclinical trials.7. Develop animal models of PSP and CBD.8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessmentof treatment.9. Develop treatments that improve the symptoms of persons with PSP and CBD.10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
Application deadlines for the Spring Cycle are usually April 1st. For the Fall Cycle the deadlineis usually October 1st. When these dates fall on a weekend or holiday, applications will beaccepted through the next business day.
CUREPSPSOCIETY FOR PROGRESSIVE SUPRANUCLEAR PALSYExecutive Plaza III11350 McCormick Road, Suite 906Hunt Valley, Maryland 21031Telephone: 410.785.7004Toll Free: 800.457.4777Website: www.curepsp.org
12next